Related Experiment Video
Updated: Jul 11, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Multivariable Model to Predict an ACTH Stimulation Test to Diagnose Adrenal Insufficiency Using Previous Test Results
Neil Richard Lawrence1,2, Muhammad Fahad Arshad1,3, Riccardo Pofi4
1Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield S10 2TN, UK.
This study created a mathematical tool to predict the results of a follow-up adrenal function test by combining a patient's current morning cortisol levels with their historical test data. By using this model, clinicians can more accurately estimate if a patient has recovered from adrenal insufficiency without needing to perform every repeat test.
Area of Science:
- Endocrinology research within metabolic medicine
- Clinical diagnostics utilizing the ACTH stimulation test for patient monitoring
Background:
Clinicians frequently repeat adrenal function assessments to track recovery in patients with suspected hormonal deficiencies. No prior work had resolved whether historical data could improve the accuracy of these follow-up evaluations. That uncertainty drove the need for a predictive framework incorporating longitudinal patient records. It was already known that baseline cortisol levels provide some diagnostic utility during initial screenings. However, relying solely on single-point measurements often ignores the valuable context provided by previous clinical encounters. This gap motivated researchers to investigate if combining past results with current hormone levels enhances predictive precision. Prior research has shown that the hypothalamo-pituitary-adrenal axis exhibits complex recovery patterns over time. Understanding these dynamics requires more than just isolated snapshots of endocrine function.
Purpose Of The Study:
The study aimed to develop and validate a predictive model for estimating the results of follow-up adrenal function assessments. Researchers sought to determine if incorporating historical test data could improve diagnostic accuracy compared to current methods. Many patients undergo repeated testing to monitor the recovery of their hypothalamo-pituitary-adrenal axis, creating a need for more efficient evaluation strategies. This project addressed the challenge of predicting future hormonal responses without relying solely on new, isolated baseline measurements. By leveraging existing patient records, the team hoped to provide clinicians with a more nuanced tool for interpreting follow-up results. The motivation stemmed from the desire to reduce the burden of frequent, repetitive testing on both patients and healthcare systems. This investigation focused on identifying the most informative variables from previous clinical encounters to enhance predictive power. Ultimately, the authors intended to provide a validated, accessible resource for improving the management of adrenal health in clinical settings.
Main Methods:
Review approach involved a retrospective, longitudinal cohort design conducted at a specialized adult endocrinology facility. Investigators examined 258 paired assessments from 175 participants to establish the initial predictive framework. They subsequently validated these findings using a distinct dataset consisting of 111 patient tests collected over one year. The team employed polynomial regression techniques combined with backwards variable selection to refine the model. Eight candidate predictors were evaluated, including previous hormone baselines and calculated cortisol/ACTH ratios. The primary outcome focused on measuring cortisol levels exactly 30 minutes after the administration of Synacthen. Data collection occurred systematically to ensure the model reflected real-world clinical practice patterns. This rigorous methodology allowed for the identification of the most influential variables for predicting future hormonal responses.
Main Results:
Key findings from the literature demonstrate that the multivariable model significantly outperforms single-measurement approaches for predicting adrenal function. The combination of previous baseline cortisol, previous 30-minute cortisol, and new baseline cortisol achieved an R-squared value of 0.71. In contrast, using new baseline cortisol alone resulted in a lower R-squared value of 0.53. The model showed high diagnostic accuracy with an area under the curve of 0.97. This performance metric exceeded the 0.88 area under the curve observed when relying on new baseline cortisol alone. These results indicate that historical test data provides a robust foundation for estimating future clinical outcomes. The findings remained consistent during the validation phase using the independent cohort of 111 patients. This evidence confirms that integrating longitudinal records enhances the precision of follow-up endocrine evaluations.
Conclusions:
Synthesis and implications suggest that integrating historical data significantly improves the accuracy of follow-up adrenal function assessments. The authors propose that clinicians utilize this model to refine their monitoring strategies for patients with suspected hormonal insufficiency. This approach offers a superior alternative to relying exclusively on current morning hormone measurements. The findings indicate that previous test outcomes provide reliable indicators for future physiological responses. Researchers highlight the availability of an online tool to facilitate broader external validation of these predictive calculations. The evidence supports a shift toward more personalized diagnostic pathways in endocrinology clinics. By leveraging existing patient records, medical teams can potentially reduce the frequency of unnecessary invasive procedures. These results demonstrate that longitudinal data synthesis enhances clinical decision-making processes for adrenal health.
Frequently Asked Questions
The researchers propose that combining previous baseline and 30-minute cortisol levels with new baseline cortisol yields superior predictive accuracy. This multivariable model achieved an area under the curve of 0.97, significantly outperforming the 0.88 AUC observed when using only new baseline cortisol measurements.
The team utilized polynomial regression with backwards variable selection to analyze the data. This statistical approach allowed them to identify the most significant predictors among eight candidates, including cortisol/ACTH ratios and the time interval between consecutive clinical assessments.
A tertiary UK adult endocrinology center provided the setting for this longitudinal cohort study. This location was necessary to access a large, consistent dataset of 258 paired tests from 175 adults, ensuring the model was trained on a robust, representative clinical population.
The study utilized sequential test data, including baseline adrenocorticotropin hormone and cortisol levels, to inform the model. These longitudinal records served as the foundation for identifying patterns that correlate with future 30-minute cortisol responses following Synacthen administration.
The researchers measured the cortisol response 30 minutes after the administration of Synacthen. This specific timeframe serves as the standard clinical marker for evaluating adrenal function, providing the target value for the model's predictive performance.
The authors suggest that their online calculator enables clinicians to perform external validation of the model. This resource aims to improve diagnostic precision across different healthcare settings by allowing practitioners to apply the predictive framework to their own patient cohorts.
Related Concept Videos
Hypothalamic-Pituitary Axis
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

